STOCK TITAN

UiPath, Inc. Form 4 Filings

PATH NYSE

Every Form 4 that UiPath, Inc. (PATH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow PATH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PATH filings page.

Rhea-AI Summary

UiPath, Inc. CEO, Chairman and director, who is also a 10% owner, reported selling 45,000 shares of Class A common stock on 12/16/2025 at an average price of $16.2559 per share under a pre-arranged Rule 10b5-1 trading plan.

Following this transaction, the insider beneficially owns 28,928,585 shares of UiPath Class A common stock. The filing notes that the sale prices ranged from $16.1600 to $16.3700, and detailed trade-by-trade pricing information is available upon request.

Rhea-AI Summary

UiPath, Inc.'s CEO, Chairman, director and 10% owner filed a report disclosing sales of Class A common stock. On 12/12/2025, the reporting person sold 45,000 shares at $17.9061, leaving 29,018,585 shares beneficially owned directly. On 12/15/2025, they sold another 45,000 shares at $17.2986, leaving 28,973,585 shares beneficially owned directly.

The shares were sold in compliance with a qualified selling plan adopted under Rule 10b5-1. The filing notes price ranges of $17.7300 to $18.0700 for the first set of transactions and $17.0100 to $17.5900 for the second. No derivative securities transactions were reported in this filing.

Rhea-AI Summary

UiPath, Inc. insider trade: the company’s CEO and Chairman, who is also a director and 10% owner, reported selling 45,000 shares of Class A common stock on 12/11/2025. The shares were sold at an average price of about $18.5612, within a disclosed price range of $18.38 to $18.70, under a pre-arranged Rule 10b5-1 trading plan. After this transaction, the reporting person beneficially owns 29,063,585 shares of UiPath Class A common stock.

Rhea-AI Summary

UiPath, Inc. (PATH) CEO and Chairman Daniel Dines reported a planned insider stock sale. On 12/10/2025, he sold 45,000 shares of Class A common stock at an average price of $18.6107 per share in an open market transaction coded as a sale.

The filing states the sale was made under a qualified Rule 10b5-1 trading plan, which allows preset trades to help separate personal portfolio decisions from non-public company information. Following this transaction, Dines directly beneficially owned 29,108,585 shares of UiPath Class A common stock.

Rhea-AI Summary

UiPath, Inc. insider trade: CEO and Chairman Form 4 filing

UiPath, Inc.'s CEO, Chairman, director, and 10% owner reported a sale of Class A common stock. On 12/09/2025, the reporting person sold 45,000 shares of UiPath Class A common stock in a transaction coded "S" (sale). The shares were sold at an average price of $19.1349 per share, within a reported price range from $18.9600 to $19.3000.

After this transaction, the reporting person beneficially owned 29,153,585 shares of UiPath Class A common stock, held directly. The sale was made under a qualified Rule 10b5-1 trading plan, which is a pre-established plan intended to allow insiders to sell shares according to set instructions.

Rhea-AI Summary

UiPath, Inc. CEO, Chairman and director Daniel Dines, who is also a 10% owner, reported selling Class A common stock. On 12/08/2025, he sold 45,000 shares of UiPath Class A common stock at an average price of $19.2135 per share, in an open market sale coded as an "S" transaction. The filing states that these sales were made under a pre-arranged trading plan designed to comply with Rule 10b5-1, which allows insiders to sell shares according to a preset schedule.

After this transaction, Dines beneficially owns 29,198,585 shares of UiPath Class A common stock. The price range for the reported trades was between $19.1500 and $19.4100 per share, and detailed trade breakdowns are available upon request from the company, regulators, or shareholders.

Rhea-AI Summary

UiPath, Inc. insider transaction: The company’s General Counsel and Chief Legal Officer, Brad Brubaker, reported selling 27,580 shares of UiPath Class A common stock on 12/05/2025 at an average price of $18.5546 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to a predetermined schedule. Following this transaction, he beneficially owns 635,359 shares of UiPath Class A common stock, held directly.

Rhea-AI Summary

UiPath, Inc. insider reports share sale under a pre-arranged plan. A reporting person who is a director, CEO, chairman and 10% owner of UiPath (PATH) sold 45,000 shares of Class A common stock on 12/05/2025 in an open-market transaction coded as a sale. The weighted average sale price was about $18.1952 per share, with individual trade prices ranging from $18.0900 to $18.3100.

Following this transaction, the insider beneficially owns 29,243,585 shares of UiPath Class A common stock in direct form. The filing states that the sale was made under a qualified Rule 10b5-1 trading plan, which is a pre-established program intended to allow insiders to sell shares according to preset instructions.

Rhea-AI Summary

UiPath (PATH): Insider transaction disclosed. A reporting person who serves as CEO and Chairman, and is also a director and 10% owner, sold 45,000 shares of Class A common stock on 11/05/2025. The reported transaction price was $15.0748 per share; the filing notes executions occurred between $15.00 and $15.15 under a Rule 10b5-1 trading plan. Following the sale, the reporting person directly owned 29,288,585 shares.

Rhea-AI Summary

UiPath, Inc. (PATH) insider transaction: The CEO and Chairman, who is also a Director and 10% Owner, reported selling 45,000 shares of Class A Common Stock on 11/04/2025 under a Rule 10b5-1 trading plan. The reported execution price for the sale is $15.0243, with the filing noting a trade range from $15.0000 to $15.1200.

Following this transaction, the reporting person beneficially owns 29,333,585 shares, held directly. The filing indicates the trade was executed pursuant to a pre-established plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Rhea-AI Summary

UiPath (PATH) CEO and Chairman Daniel Dines reported an insider sale. On 11/03/2025, he sold 45,000 shares of Class A common stock at an average price of $16.2264, executed under a qualified Rule 10b5-1 trading plan. The reported trade price range was $16.0500 to $16.4200.

Following this transaction, Dines beneficially owned 29,378,585 shares, held directly. He is listed as Director, Officer, and 10% Owner. The filing notes full trade details are available upon request to the company or Commission staff.

Rhea-AI Summary

UiPath (PATH) insider activity: CEO and Chairman (also a 10% owner) reported selling 45,000 shares of Class A common stock on 10/31/2025 at an average price of $15.7171. The transaction was executed pursuant to a qualified Rule 10b5-1 trading plan.

Following the sale, the reporting person beneficially owns 29,423,585 shares, held directly. The filing notes the sale prices ranged from $15.5700 to $15.8500, with full trade-by-trade details available upon request.

Rhea-AI Summary

UiPath (PATH) insider transaction: A reporting person who is the CEO and Chairman, Director, and a 10% Owner reported selling 45,000 shares of Class A common stock on 10/30/2025 at an average price of $15.7254 under a Rule 10b5-1 trading plan. The disclosed trade occurred within a price range of $15.4500 to $16.0000. Following the sale, the filer beneficially owns 29,468,585 shares, held directly.

Rhea-AI Summary

UiPath (PATH) CEO and Chairman, who is also a Director and 10% Owner, reported open-market sales of Class A common stock under a Rule 10b5-1 trading plan. He sold 45,000 shares on 10/27/2025 at a weighted average price of $16.726, 45,000 shares on 10/28/2025 at $17.1632, and 45,000 shares on 10/29/2025 at $16.2874.

Following these transactions, the reporting person beneficially owned 29,513,585 shares of Class A common stock. A footnote states he no longer has a reportable beneficial interest in 240,000 shares previously included in ownership reports.

Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its CEO and Chairman, who is also a 10% owner. On 10/24/2025, he sold 45,000 shares of Class A common stock in an open market sale pursuant to a Rule 10b5-1 trading plan. The sale price averaged $15.4578, with a disclosed range from $15.3200 to $15.5600.

Following the transaction, the reporting person beneficially owns 29,648,585 shares directly and 240,000 shares indirectly through a spouse.

Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its CEO and Chairman. On 10/23/2025, the reporting person sold 45,000 Class A shares at an average price of $15.1853, with a range of $15.0000–$15.3300, pursuant to a Rule 10b5-1 plan. Following the sale, beneficial ownership stood at 29,693,585 shares directly and 240,000 shares indirectly by spouse.

Rhea-AI Summary

UiPath (PATH) insider transaction: The company’s CEO and Chairman, who is also a Director and 10% owner, reported selling 45,000 shares of Class A common stock on 10/22/2025 under a Rule 10b5-1 trading plan. The reported price was $15.5312, with trades executed in a range from $15.3700 to $15.8000.

Following the sale, the reporting person beneficially owns 29,738,585 shares directly and 240,000 shares indirectly through a spouse. This filing reflects a planned disposition under a qualified selling plan and provides price-range details upon request.

Rhea-AI Summary

UiPath (PATH) insider transaction: The company’s Chief Accounting Officer reported selling 5,000 shares of Class A common stock on 10/22/2025 (Transaction Code S) under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $15.4673, with trade prices ranging from $15.3200 to $15.8000. Following this sale, the reporting person beneficially owns 182,776 shares, held directly.

Rhea-AI Summary

UiPath (PATH) CEO and Chairman (also a Director and 10% Owner) reported a Form 4 sale of 45,000 Class A shares on 10/21/2025, executed under a Rule 10b5-1 trading plan. The weighted average price was $15.5692, with individual trade prices ranging from $15.4700 to $15.6800.

Following the transaction, the reporting person beneficially owns 29,783,585 shares directly and 240,000 shares indirectly through a spouse. The transaction code was S (open market sale).

Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/21/2025, the officer sold 10,000 Class A shares at a price of $15.68 per share under a Rule 10b5-1 pre-arranged trading plan.

Following this sale, the officer beneficially owns 192,776 shares, held directly. This disclosure was filed on Form 4 and reflects a routine, planned transaction by a company officer.

Rhea-AI Summary

UiPath, Inc. (PATH) CEO and Chairman reported an insider sale under a Rule 10b5-1 trading plan. On 10/20/2025, the reporting person sold 45,000 shares of Class A common stock at a price reported as $15.7116, with the filing noting a transaction price range from $15.6300 to $15.8700.

After this transaction, the reporting person beneficially owned 29,828,585 shares directly, and an additional 240,000 shares indirectly through a spouse. The individual is listed as a Director, 10% Owner, and Officer (CEO and Chairman). The sale was executed pursuant to a qualified selling plan adopted under Rule 10b5-1.

Rhea-AI Summary

UiPath (PATH) Form 4: The company’s Chief Accounting Officer reported a sale of Class A common stock. On 10/20/2025, the officer sold 10,000 shares at $15.65 per share, disclosed with transaction code “S”. The filing notes the sale was made under a qualified Rule 10b5-1 trading plan.

Following this transaction, the reporting person beneficially owns 202,776 shares with direct ownership.

Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/17/2025, the officer sold 10,000 shares of Class A common stock at an average price of $15.7345, executed under a qualified Rule 10b5-1 trading plan. Following the sale, the officer beneficially owns 212,776 shares directly. The filing notes a transaction price range from $15.6000 to $15.8700.

Rhea-AI Summary

UiPath (PATH) insider transaction: CEO and Chairman Daniel Dines, also a Director and 10% Owner, reported a sale of 45,000 shares of Class A common stock at $15.62 on 10/17/2025. The filing notes the sale was executed under a qualified Rule 10b5-1 trading plan.

Following the transaction, he beneficially owned 29,873,585 shares directly. An additional 240,000 shares are reported as indirectly owned by his spouse.

Rhea-AI Summary

UiPath, Inc. (PATH) insider transaction: CEO, Chairman, Director, and 10% owner Daniel Dines reported a sale of 122,734 Class A shares on 10/16/2025. The sale was executed under a qualified Rule 10b5-1 trading plan. The filing notes a weighted average price of $17.2113, with individual trade prices ranging from $16.7400 to $17.4700.

Following the reported transactions, the filing lists 29,918,585 Class A shares as directly beneficially owned and 240,000 shares indirectly beneficially owned by spouse. The form also references indirect holdings through Ice Vulcan Holding Limited, over which Mr. Dines has sole voting and investment power via control of the parent entity.

Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/16/2025, the officer sold a total of 10,000 Class A shares in two trades executed under a pre‑arranged Rule 10b5-1 plan.

The first sale was 8,300 shares at a weighted average price of $16.2211 (price range $15.8100–$16.7700). The second was 1,700 shares at a weighted average price of $16.9918 (range $16.8100–$17.4900). Following these transactions, the officer beneficially owns 222,776 shares, held directly.

Rhea-AI Summary

UiPath (PATH) reported an insider transaction by its GC & Chief Legal Officer, Brad Brubaker. On 10/15/2025, he sold 27,580 shares of Class A common stock in an open-market transaction executed under a Rule 10b5-1 trading plan.

The reported average price was $16.6761, with trades occurring in a range from $16.2100 to $17.2000. Following the sale, Brubaker beneficially owns 662,939 shares, held directly.

Rhea-AI Summary

UiPath (PATH) CEO Daniel Dines reported an insider sale. A Form 4 shows the sale of 122,734 shares of Class A common stock on 10/15/2025, executed pursuant to a Rule 10b5-1 trading plan.

The filing lists a price of $16.9245 and notes trades occurred within a range of $16.7200 to $17.0600. Footnotes indicate certain shares are held through Ice Vulcan Holding Limited, with Mr. Dines retaining sole voting and investment power through affiliated entities. He is identified as Director, CEO and Chairman, and a 10% Owner.

Rhea-AI Summary

UiPath (PATH) filed a Form 4 reporting that its Chief Accounting Officer sold Class A common stock pursuant to a Rule 10b5-1 plan. The officer sold 10,000 shares on 10/14/2025 at an average price of $16.5351 (price range $16.1200–$16.9000) and 10,000 shares on 10/15/2025 at an average price of $16.6801 (price range $16.2400–$17.1100).

Following these transactions, the reporting person beneficially owned 232,776 shares, held directly.

Rhea-AI Summary

UiPath (PATH) COO & CFO Ashim Gupta reported insider transactions on 10/09/2025. He exercised 148,009 stock options at $0.7533 per share and executed open‑market sales under a Rule 10b5‑1 trading plan.

Sales were reported in three blocks: 181,745 shares at an average price of $17.0122 (range $16.2800–$17.2700), 32,144 shares at $17.7403 (range $17.2800–$18.2700), and 26,985 shares at $18.5263 (range $18.2800–$18.7300). Following these transactions, he directly owned 696,117 Class A shares.

Rhea-AI Summary

UiPath (PATH) CEO and Chairman Daniel Dines reported open‑market sales under a Rule 10b5‑1 plan. He sold 122,734 Class A shares on 10/13/2025 at an average price of $17.0604 (price range $16.8700–$17.2900) and 122,734 shares on 10/14/2025 at an average price of $16.3347 (range $16.0700–$16.8100).

Following these transactions, reported holdings include 245,468 Class A shares held indirectly via Ice Vulcan Holding Limited, 29,918,585 Class A shares held directly, and 240,000 Class A shares held indirectly by spouse.

Rhea-AI Summary

UiPath (PATH) disclosed a Form 4 showing its Chief Accounting Officer sold 10,000 shares of Class A common stock on 10/13/2025 at an average price of $17.0056 under a Rule 10b5-1 trading plan.

Following the sale, the officer directly owned 252,776 shares. The reported trades occurred within a price range of $16.6400 to $17.3400.

Rhea-AI Summary

UiPath, Inc. (PATH) reported an insider transaction by its CEO and Chairman, who is also a Director and 10% Owner. On 10/10/2025, the reporting person sold 122,734 shares of Class A Common Stock (Transaction Code S) at an average price of $18.3721, executed under a qualified Rule 10b5-1 selling plan. The price range for the sale was $18.1600 to $18.5900.

Following the transaction, the filing lists beneficial ownership positions as: 29,918,585 shares direct; 490,936 shares indirect (see footnote regarding Ice Vulcan Holding Limited); and 240,000 shares indirect by spouse.

Rhea-AI Summary

UiPath insider sale reported by CEO and Chairman Daniel Dines. The filing shows that on 10/09/2025 Mr. Dines (reporting person) caused the sale of multiple blocks of Class A Common Stock, including a discrete disposal of 29,918,585 shares and a separate sale of 122,734 shares at an average price range of $16.21 to $16.98 (reported price point $16.5743). The Form 4 states the trades were executed under a Rule 10b5-1 selling plan. After the reported transactions, Mr. Dines retains indirect beneficial ownership of 613,670 shares and a separate indirect holding of 240,000 shares held by his spouse via related entities, with voting and investment power retained through Ice Vulcan entities.

Rhea-AI Summary

Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), reported a sale of 122,734 shares of Class A common stock executed on 10/08/2025 under a qualified Rule 10b5-1 selling plan. The filing lists a reported price figure of $14.8901 and a disclosed transaction price range from $14.7700 to $15.0400. After the reported transactions the document shows 736,404 shares beneficially owned in an indirect form through Ice Vulcan Holding Limited, an entity ultimately owned by Mr. Dines; the filing states he retains sole voting and investment power over those shares. The sale was executed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Summary

UiPath insider sale under written plan: The Form 4 shows that Daniel Dines, CEO and Chairman of UiPath, sold 122,733 shares of Class A common stock on 10/07/2025 under a Rule 10b5-1 qualified selling plan. The reported sale price on the form is $14.9899, with the disclosed transaction price range of $14.70 to $15.14. After the reported transaction, the form lists 859,138 shares beneficially owned indirectly and describes ownership through Ice Vulcan entities, with Mr. Dines retaining sole voting and investment power. The filing was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Summary

UiPath, Inc. (PATH) reporting person Brad Brubaker, GC & Chief Legal Officer, disclosed a sale of 66,665 shares of Class A common stock on 10/06/2025 under a pre-established Rule 10b5-1 selling plan. The reported sale prices ranged from $15.0000 to $15.0050, and after the transaction Mr. Brubaker beneficially owned 690,519 shares directly.

The filing confirms the sale was executed pursuant to a qualified 10b5-1 plan and the filer offered to provide transaction-level price details to the Commission staff or security holders upon request. No derivative transactions or other changes in beneficial ownership were reported on this form.

Rhea-AI Summary

UiPath (PATH) CEO and Chairman Daniel Dines reported an open-market sale of 122,733 shares of Class A common stock on 10/06/2025, coded “S,” executed under a Rule 10b5-1 trading plan. The weighted average sales price was $14.2442, with trades between $13.9200 and $14.5000. Following the sale, he beneficially owned 29,918,585 shares directly, 981,871 shares indirectly (per Ice Vulcan structure), and 240,000 shares indirectly by spouse.

Rhea-AI Summary

UiPath director, CEO and 10% owner Daniel Dines reported multiple dispositions on 10/03/2025. The filing shows a sale of 122,733 shares of Class A common stock at prices ranging from $12.75 to $13.13, executed under a qualified Rule 10b5-1 selling plan. The report also records a separate disposition of 29,918,585 Class A shares and indicates beneficial ownership of 1,104,604 shares indirectly through Ice Vulcan Holding Limited, plus 240,000 shares held indirectly by his spouse. The form is signed by an attorney-in-fact on behalf of Mr. Dines.

Rhea-AI Summary

Daniel Dines, who serves as CEO and Chairman of UiPath, Inc. (PATH) filed a Form 4 reporting insider sales executed on 10/02/2025. The filing discloses the sale of 122,733 shares of Class A common stock at prices ranging from $12.76 to $13.03 under a qualified Rule 10b5-1 selling plan. After the reported transactions, the filing shows 1,227,337 shares beneficially owned indirectly through Ice Vulcan Holding Limited, while other entries list 29,918,585 and 240,000 shares in separate lines. A footnote explains that Ice Vulcan entities are ultimately controlled by Mr. Dines, who retains sole voting and investment power for those shares.

Rhea-AI Summary

UiPath insider transaction by COO & CFO Ashim Gupta — On 10/01/2025 the reporting person, Ashim Gupta, recorded a disposition of 71,009 shares of Class A common stock at a price of $13.38 per share. The Form 4 shows 71,009 shares were disposed and that 788,982 shares remain beneficially owned by Mr. Gupta in a direct ownership form.

The filing explains the 71,009-share disposition represents shares withheld by the issuer to satisfy a tax obligation arising when restricted stock units vested and settled. The form is filed individually and was signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Summary

Ramani Hitesh, Chief Accounting Officer of UiPath, Inc. (PATH), reported a transaction dated 10/01/2025 on Form 4. The filing shows 26,058 shares of Class A common stock were disposed of at a price of $13.38 per share. The filing records 262,776 shares beneficially owned by the reporting person after the transaction.

The form states the 26,058 shares were withheld by the issuer to satisfy a tax obligation arising from the vesting and settlement of restricted stock units (RSUs). The Form 4 was filed by one reporting person and signed by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Summary

Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH) reported the sale of 122,733 shares of Class A common stock on 10/01/2025 under a qualified Rule 10b5-1 selling plan. The reported sale prices ranged from $13.2100 to $13.5600. The filing shows beneficial ownership through Ice Vulcan Holding Limited and related entities: following the reported transaction(s) the filing lists 1,350,070 shares beneficially owned indirectly and additional reported holdings of 29,918,585 shares and 240,000 shares noted as direct or indirect on separate lines. The filing was signed by an attorney-in-fact and includes explanatory footnotes about the 10b5-1 plan and ownership structure.

Rhea-AI Summary

UiPath, Inc. (PATH) Form 4 summary: On 09/30/2025, Reporting Person Daniel Dines reported the disposition of 122,733 shares of Class A common stock under code "S" (sale) pursuant to a qualified Rule 10b5-1 selling plan. The reported price range for the transactions was $14.71 to $14.93 per share. Following the reported transaction(s), the filing shows 1,472,803 shares of Class A common stock beneficially owned indirectly by Ice Vulcan Holding Limited, and an additional 240,000 shares held indirectly by spouse (as disclosed). The filing explains that IceVulcan Investments Ltd. is the sole shareholder of Ice Vulcan Holding Limited and that Mr. Dines is the sole shareholder of IceVulcan Investments Ltd., retaining sole voting and investment power over the shares held by Ice Vulcan Holding Limited.

Rhea-AI Summary

Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), reported transactions dated 09/29/2025 on Form 4 showing dispositions of Class A common stock. The filing lists two dispositions on that date: 122,733 shares sold at prices ranging from $12.1750 to $12.4600 and a larger reported disposition of 29,918,585 shares. Following the reported transactions, the filing shows 1,595,536 shares beneficially owned indirectly by Ice Vulcan Holding Limited and 240,000 shares indirectly held by spouse. The sales were made under a Rule 10b5-1 qualified selling plan. The filing also discloses that IceVulcan Investments Ltd. is the sole shareholder of Ice Vulcan Holding Limited and that Mr. Dines retains sole voting and investment power.

Rhea-AI Summary

UiPath insider sale and holdings update. The Form 4 filed for UiPath, Inc. (PATH) shows reporting person Daniel Dines, identified as CEO and Chairman and a 10% owner, reported transactions dated 09/26/2025. The filing discloses a sale of 122,733 shares of Class A common stock at prices ranging from $11.96 to $12.17, with a reported weighted price of $12.0815. After the reported transactions, the amount of securities beneficially owned is reported as 1,718,269 shares indirectly.

The filing also lists a disposition line for 29,918,585 shares of Class A common stock and notes an indirect holding of 240,000 shares by spouse. Footnotes state the sold shares were sold under a Rule 10b5-1 selling plan and that the shares are held through Ice Vulcan entities, with Mr. Dines retaining sole voting and investment power over those holdings.

Rhea-AI Summary

UiPath insider share sale and holdings disclosure. The Form 4 shows that on 09/25/2025 reporting person Daniel Dines disposed of 122,733 shares of UiPath Class A common stock under transaction code S, at prices ranging from $11.89 to $12.16. The filing states the sale was made under a qualified Rule 10b5-1 selling plan. The report also discloses beneficial ownership through Ice Vulcan Holding Limited, with Mr. Dines retaining sole voting and investment power. The filing includes additional reported holdings of 29,918,585 and 240,000 Class A shares in separate lines as shown.

Rhea-AI Summary

Daniel Dines, listed as CEO and Chairman and a 10% owner of UiPath, reported sales of Class A common stock on 09/24/2025. The filing shows a sale of 122,733 shares executed under a Rule 10b5-1 selling plan at prices ranging from $12.33 to $12.63, leaving 1,963,735 shares beneficially owned indirectly through Ice Vulcan Holding Limited. The filing also records a reported disposal of 29,918,585 shares and notes an indirect holding of 240,000 shares by spouse. Footnotes state IceVulcan Investments Ltd. is the sole shareholder of Ice Vulcan Holding Limited and Mr. Dines retains sole voting and investment power.

Rhea-AI Summary

Daniel Dines, reporting person and UiPath CEO and Chairman, reported a sale of 122,733 shares of Class A common stock on 09/23/2025 under a qualified Rule 10b5-1 selling plan. The reported sale prices ranged from $12.84 to $13.21. The filing shows the reporting person retains indirect beneficial ownership of 2,086,468 shares through Ice Vulcan Holding Limited and notes 240,000 shares held indirectly by a spouse. The filing identifies IceVulcan Investments Ltd. as sole shareholder of Ice Vulcan Holding Limited and states Mr. Dines retains sole voting and investment power over those shares. The Form 4 was filed by one reporting person and executed by an attorney-in-fact on the same date.

Rhea-AI Summary

UiPath insider sale under 10b5-1 plan. Director and CEO Daniel Dines sold 122,733 shares of Class A common stock on 09/22/2025 under a Rule 10b5-1 plan at prices ranging from $12.03 to $12.355 per share. After the reported transactions the filing discloses beneficial ownership of 2,209,201 shares held indirectly through Ice Vulcan Holding Limited, and notes additional positions referenced in the table. The filing states Mr. Dines is the sole shareholder of IceVulcan Investments Ltd. and retains sole voting and investment power over shares held by Ice Vulcan Holding Limited.